1 |
Polonelli L, Conti S, Gerloni M, et al. 'Antibiobodies': antibiotic-like anti-idiotypic antibodies. J Med Vet Mycol 1991;29:235-242.
DOI
|
2 |
Cassone A, Rappuoli R. Universal vaccines: shifting to one for many. MBio 2010;1:e00042-10.
|
3 |
Clemons KV, Stevens DA. Vaccines against coccidioidomycosis: past and current developments. J Invasive Fungal Infect 2011;5:99-109.
|
4 |
Stevens DA, Clemons KV, Liu M. Developing a vaccine against aspergillosis. Med Mycol 2011;49 Suppl 1:S170-S176.
DOI
ScienceOn
|
5 |
Cassone A. Fungal vaccines: real progress from real challenges. Lancet Infect Dis 2008;8:114-124.
DOI
ScienceOn
|
6 |
Pachl J, Svoboda P, Jacobs F, et al. A randomized, blinded, multicenter trial of lipid-associated amphotericin B alone versus in combination with an antibody-based inhibitor of heat shock protein 90 in patients with invasive candidiasis. Clin Infect Dis 2006;42:1404-1413.
DOI
ScienceOn
|
7 |
Torosantucci A, Bromuro C, Chiani P, et al. A novel glyco-conjugate vaccine against fungal pathogens. J Exp Med 2005;202:597-606.
DOI
ScienceOn
|
8 |
Rachini A, Pietrella D, Lupo P, et al. An anti-beta-glucan monoclonal antibody inhibits growth and capsule formation of Cryptococcus neoformans in vitro and exerts therapeutic, anticryptococcal activity in vivo. Infect Immun 2007;75:5085-5094.
DOI
ScienceOn
|
9 |
Polonelli L, De Bernardis F, Conti S, et al. Idiotypic intravaginal vaccination to protect against candidal vaginitis by secretory, yeast killer toxin-like anti-idiotypic antibodies. J Immunol 1994;152:3175-3182.
|
10 |
Baquir B, Lin L, Ibrahim AS, et al. Immunological reactivity of blood from healthy humans to the rAls3p-N vaccine protein. J Infect Dis 2010;201:473-477.
DOI
ScienceOn
|